Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07021703 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Clinical Trial of Rabies Vaccine（Human Diploid Cell）for Human Use,Freeze-dried

StatusRecruiting
PhasePhase 1
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated June 15, 2025 (before its estimated July 28, 2025 completion). Its status may not reflect the trial's current state.

Record History

  1. Study First Submitted
The Phase 1 clinical trial of the freeze-dried human rabies vaccine (human diploid cells) will be conducted on participants aged 10 to 60. This study will design a single-arm, randomized, open-access trial with different immunization schedules (5-dose schedule and 2-1-1 schedule) to evaluate the safety and tolerability of the vaccine in participants aged 10 to 60
Trial Details
NCT Number NCT07021703
Lead Sponsor Ningbo Rongan Biological Pharmaceutical Co., Ltd.
Conditions
(from sponsor)		 Rabies
Related terms Rabies
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov